Meaning and therapeutic potential of microbial recognition of host glycoconjugates.
about
Cloning and expression of the histo-blood group Pk UDP-galactose: Ga1beta-4G1cbeta1-cer alpha1, 4-galactosyltransferase. Molecular genetic basis of the p phenotypeHelicobacter pylori SabA adhesin in persistent infection and chronic inflammationStructural insights into the regulation of sialic acid catabolism by the Vibrio vulnificus transcriptional repressor NanRForssman synthetase expression results in diminished shiga toxin susceptibility: a role for glycolipids in determining host-microbe interactionsUse of an affinity proteomics approach for the identification of low-abundant bacterial adhesins as applied on the Lewis(b)-binding adhesin of Helicobacter pylori.A new family of potent AB(5) cytotoxins produced by Shiga toxigenic Escherichia coli.Neu5Acalpha3Gal is part of the Helicobacter pylori binding epitope in polyglycosylceramides of human erythrocytes.Sequence and structural features of carbohydrate binding in proteins and assessment of predictability using a neural networkEnterovirus 70 binds to different glycoconjugates containing alpha2,3-linked sialic acid on different cell lines.Binding of Actinobacillus pleuropneumoniae lipopolysaccharides to glycosphingolipids evaluated by thin-layer chromatography.Helicobacter pylori and neutrophils: sialic acid-dependent binding to various isolated glycoconjugates.Anti-adhesive strategies in the prevention of infectious disease at mucosal surfaces.A second uniquely human mutation affecting sialic acid biology.Structural and quantitative evidence for dynamic glycome shift on production of induced pluripotent stem cells.Mechanism of uptake and incorporation of the non-human sialic acid N-glycolylneuraminic acid into human cells.Bioengineered bugs expressing oligosaccharide receptor mimics: toxin-binding probiotics for treatment and prevention of enteric infectionsA glycobiology review: carbohydrates, lectins and implications in cancer therapeuticsThe sweet and sour of serological glycoprotein tumor biomarker quantification.Streptococcus pyogenes glycoprotein-binding strepadhesin activity is mediated by a surface-associated carbohydrate-degrading enzyme, pullulanase.Enhanced bacterial virulence through exploitation of host glycosaminoglycans.Fighting infectious diseases with inhibitors of microbial adhesion to host tissues.Changes in anti-thyroglobulin IgG glycosylation patterns in Hashimoto's thyroiditis patients.Stopping bacterial adhesion: a novel approach to treating infections.N-glycolyl GM1 ganglioside as a receptor for simian virus 40.Investigation of glycan evolution based on a comprehensive analysis of glycosyltransferases using phylogenetic profiling.Anti-glycan antibodies as biomarkers for diagnosis and prognosis.Enterotoxigenic Escherichia coli modulates host intestinal cell membrane asymmetry and metabolic activity.Relevance of MUC1 mucin variable number of tandem repeats polymorphism in H pylori adhesion to gastric epithelial cells.Aberrant glycosylation as biomarker for cancer: focus on CD43.A small region of the natural killer cell receptor, Siglec-7, is responsible for its preferred binding to alpha 2,8-disialyl and branched alpha 2,6-sialyl residues. A comparison with Siglec-9.Role of lactosyl glycan sequences in inhibiting enteropathogenic Escherichia coli attachment.Novel binding epitope for Helicobacter pylori found in neolacto carbohydrate chains: structure and cross-binding properties.A new kind of carbohydrate array, its use for profiling antiglycan antibodies, and the discovery of a novel human cellulose-binding antibody.Oligosaccharide microarrays for high-throughput detection and specificity assignments of carbohydrate-protein interactions.Bacterial inclusion bodies as potential synthetic devices for pathogen recognition and a therapeutic substance release.Salmonella Typhimurium Enzymatically Landscapes the Host Intestinal Epithelial Cell (IEC) Surface Glycome to Increase Invasion.A heat labile soluble factor from Bacteroides thetaiotaomicron VPI-5482 specifically increases the galactosylation pattern of HT29-MTX cells.Expression, purification and crystallization of the C-terminal LRR domain of Streptococcus pyogenes protein 0843Synthesis and application of glycoconjugate-functionalized magnetic nanoparticles as potent anti-adhesion agents for reducing enterotoxigenic Escherichia coli infections.Loss of N-glycolylneuraminic acid in human evolution. Implications for sialic acid recognition by siglecs.
P2860
Q22253436-7904C39E-EA14-4087-AF0F-C03C746D02F5Q24650188-FF186258-2089-42FB-95D4-FB84F93955F6Q27678974-36868848-7718-4250-B476-C78E505D6055Q28512095-C8B764F5-8D42-413D-8200-BA1AABE684B4Q30846084-2C244CF7-627B-40DE-B4E9-35E407079874Q30940276-42B4032C-9AEB-4CD9-85DF-C6A0BDC80FF1Q31431621-0A1181D6-41A9-4973-BEA0-D23DF6918B03Q33268099-BAEA8218-2043-4DDF-9329-6D60BDECE850Q33788674-6F59789D-37CA-4F08-945E-200154229816Q34001958-3E32F06D-C721-4F96-AA11-C0DD1990CD1FQ34002684-95B09499-44D6-46A6-89EA-64D6B6DEB5D7Q34074980-7892B2BD-BE26-4A2D-8C52-26C172B2F088Q34090387-505028B3-B7D8-4818-B156-288277F79B38Q34302732-B4945B8D-E2C8-4848-A806-8E5E6BE5287CQ34370155-E9707260-8E14-4845-B074-D34E93732107Q34518407-3690C184-5B30-470B-9B3C-D28068F0E636Q34524965-471D1AD0-3A84-49B6-A7D5-2A3DFBCF9230Q34580285-507FC165-7041-4D24-B69C-D1BB8DA8DBF4Q34581867-DA83717E-B967-48F5-9984-C40972DB5A3DQ34611457-35683793-0632-4B03-B47C-B4F0853A2C50Q34680458-39FECBDD-6247-4F61-B9C2-E274E8ED4DBFQ35055090-C0F04B41-B732-41A4-998A-67E63D47F055Q36222763-0EE362D9-2143-4C91-B5A9-FA4C12E29AF2Q36315769-A81D1380-1EB1-4277-A3CA-010709CD6E2EQ36531717-70E48C62-6D9E-49E7-9CED-7789308E605EQ36560795-B21C3724-077C-4F82-8DEF-53DD4A68DDA4Q37033002-92E5F172-48B3-4490-8D2E-88D311C0EF84Q37220689-10A312D6-C774-4F62-BB10-309F0AD645B7Q37618865-2266DB9D-FCD6-4862-80AC-0990252DA08AQ38293996-B1FA827F-9585-44BD-8B82-099416FC3264Q38323546-52A702B5-2314-43F1-9E1B-08AF45B2AD21Q38329815-4383DD88-AB38-413B-AC83-D2316B90EEA9Q38352751-2A9A0025-CE10-408F-BA6E-AAF5DF327E8FQ38363175-351E7AFF-43A5-4067-A656-5CCA7D7F3707Q39517242-2DD445E0-79C7-4944-BCCE-9D58AD3BB845Q40501498-B2D9D43F-92DA-40AB-B3EC-5FDC3367D423Q40813269-AF1BCB11-B5CE-405F-8336-38C754BE54D3Q40920943-64A5D38E-76C7-45C8-BEB0-F8D9CFCE973EQ41303130-6A779DEA-C54A-4D3D-96FF-EED107CF1073Q41725570-3F1A0FEB-73A4-4FDA-ABFE-DACB4DD5D2C8
P2860
Meaning and therapeutic potential of microbial recognition of host glycoconjugates.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Meaning and therapeutic potential of microbial recognition of host glycoconjugates.
@en
Meaning and therapeutic potential of microbial recognition of host glycoconjugates.
@nl
type
label
Meaning and therapeutic potential of microbial recognition of host glycoconjugates.
@en
Meaning and therapeutic potential of microbial recognition of host glycoconjugates.
@nl
prefLabel
Meaning and therapeutic potential of microbial recognition of host glycoconjugates.
@en
Meaning and therapeutic potential of microbial recognition of host glycoconjugates.
@nl
P2860
P1476
Meaning and therapeutic potential of microbial recognition of host glycoconjugates.
@en
P2093
Karlsson KA
P2860
P356
10.1046/J.1365-2958.1998.00854.X
P407
P577
1998-07-01T00:00:00Z